Rocket, Lab

Rocket Lab Weathers Blue Origin Shock as SpaceX IPO Filing Resets Sector Metrics

03.06.2026 - 01:03:58 | boerse-global.de

After Blue Origin's New Glenn explosion sent Rocket Lab shares down 14.7%, reassurances and SpaceX's IPO filing boosted the stock. Strong Q1 revenue and $2.2B backlog underpin fundamentals.

Rocket Lab Weathers Blue Origin Shock as SpaceX IPO Filing Resets Sector Metrics - Bild: ĂĽber boerse-global.de
Rocket Lab Weathers Blue Origin Shock as SpaceX IPO Filing Resets Sector Metrics - Bild: ĂĽber boerse-global.de

The space sector endured a jarring start to the week after a catastrophic engine test at Blue Origin sent shockwaves through the market — literally and figuratively. The explosion of a New Glenn rocket at Cape Canaveral on May 28 registered as a magnitude 2.5 seismic event, and the fallout rippled across publicly traded space stocks. Rocket Lab, despite having no direct involvement, saw its shares crumple 14.7% in Monday’s session as investors fretted over potential launch infrastructure bottlenecks and cascading delays in satellite deployment.

The recovery came swiftly. Blue Origin CEO Dave Limp confirmed on Tuesday that the New Glenn rocket would fly again before year-end, adding that critical infrastructure such as fuel storage and the water tower had survived the blast intact. The reassurances helped calm the broader market: Redwire, Intuitive Machines and Planet Labs all bounced from steep losses, while Rocket Lab gained roughly 3% to trade at €108.60. The stock remains nearly 12% lower over a seven-day stretch and sits about 16% below the 52-week high of €129.20 set on May 27.

Yet the Blue Origin incident is only one half of the story shaping Rocket Lab’s near-term trajectory. On June 1, SpaceX filed an amended registration statement (Form S-1/A) with the SEC, a move that immediately refocused attention on publicly traded space infrastructure plays. MarketBeat flagged Rocket Lab on June 2 as the most direct publicly-listed beneficiary of the SpaceX IPO narrative, given its overlapping exposure to launch services, spacecraft manufacturing and national security missions. The U.S.-listed shares closed that day at $122.81, up a modest 0.34%, after swinging between $122.67 and $128.02 on volume of 12.63 million shares. The market capitalization stood at roughly $74.35 billion.

Should investors sell immediately? Or is it worth buying Rocket Lab?

The juxtaposition of these two events underscores the dual pressures on Rocket Lab: a sector-wide jolt from a competitor’s mishap versus the valuation benchmark set by the industry’s looming IPO. Analysts caution that while the SpaceX filing is a tailwind for the entire space ecosystem, it does not directly expand Rocket Lab’s order book. The company’s own fundamentals will have to carry the weight.

Those fundamentals remain robust. First-quarter 2026 revenue hit $200.3 million, a 63.5% year-over-year increase, with GAAP gross margin at 38.2% and a backlog of $2.2 billion. Rocket Lab now has more than 70 contracted missions on its manifest, after signing 31 new Electron and HASTE launch contracts plus five dedicated Neutron missions during the quarter. For the second quarter, management guided for revenue between $225 million and $240 million, with GAAP gross margin of 33% to 35% and a non-GAAP margin of 38% to 40%. The adjusted EBITDA loss is expected to narrow to a range of $20 million to $26 million — a metric investors are watching closely to gauge operational leverage.

Adding to the narrative of diversification, Rocket Lab closed its acquisition of Motiv Space Systems on May 26, rebranding the unit as Rocket Lab Robotics. The deal brings in-space robotics, motion-control systems and precision mechanisms — including solar-array drives, antenna and thruster gimbals, filter wheels and focusing mechanisms — that complement the company’s satellite manufacturing capabilities and its ambitions in orbital infrastructure, such as space-based data centers requiring solar arrays of 100 kilowatts or more. The acquisition reduces reliance on a single launch window, a strategic hedge in a period when technical setbacks are creating industry-wide uncertainty.

The central question for investors is whether Rocket Lab can sustain its premium as the tightest publicly traded proxy for SpaceX’s business model, even as the IPO process injects a new reference point for sector valuations. The stock already trades on expectations that encompass launch services, satellite production, hypersonics, defense space systems and orbital infrastructure — a slate of growth vectors that explains the negative price-to-earnings ratio. The next proving ground will be Rocket Lab’s ability to deliver on Q2 revenue guidance, maintain margin discipline, advance the Neutron rocket program and convert its bulging contract backlog into cash flow. For now, the company is navigating a sector in flux, with one foot in the rubble of a competitor’s test stand and the other in the slipstream of a historic IPO.

Ad

Rocket Lab Stock: New Analysis - 3 June

Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab analysis...

So schätzen die Börsenprofis Rocket Aktien ein!

<b>So schätzen die Börsenprofis Rocket Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
FĂĽr. Immer. Kostenlos.
en | US7731211089 | ROCKET | boerse | 69474421 |